BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36002559)

  • 1. In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.
    Hernandez A; Muñoz-Mármol AM; Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí-Lluciá O; Martinez-García M; Mallo M; Gut M; Del Barco S; Gallego O; Dabad M; Mesia C; Bellosillo B; Domenech M; Vidal N; Aldecoa I; de la Iglesia N; Balana C
    Sci Rep; 2022 Aug; 12(1):14439. PubMed ID: 36002559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
    Parker BC; Annala MJ; Cogdell DE; Granberg KJ; Sun Y; Ji P; Li X; Gumin J; Zheng H; Hu L; Yli-Harja O; Haapasalo H; Visakorpi T; Liu X; Liu CG; Sawaya R; Fuller GN; Chen K; Lang FF; Nykter M; Zhang W
    J Clin Invest; 2013 Feb; 123(2):855-65. PubMed ID: 23298836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.
    Bao ZS; Chen HM; Yang MY; Zhang CB; Yu K; Ye WL; Hu BQ; Yan W; Zhang W; Akers J; Ramakrishnan V; Li J; Carter B; Liu YW; Hu HM; Wang Z; Li MY; Yao K; Qiu XG; Kang CS; You YP; Fan XL; Song WS; Li RQ; Su XD; Chen CC; Jiang T
    Genome Res; 2014 Nov; 24(11):1765-73. PubMed ID: 25135958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic Fusions in Gliomas: An Institutional Experience.
    Polivka J; Svajdler M; Priban V; Mracek J; Kasik P; Martinek P; Ptakova N; Sharif Bagheri M; Shetti D; Pesta M; Potuznik P; Topolcan O
    Anticancer Res; 2022 Apr; 42(4):1933-1939. PubMed ID: 35347013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.
    Shah N; Lankerovich M; Lee H; Yoon JG; Schroeder B; Foltz G
    BMC Genomics; 2013 Nov; 14(1):818. PubMed ID: 24261984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metabolic function of FGFR3-TACC3 gene fusions in cancer.
    Frattini V; Pagnotta SM; Tala ; Fan JJ; Russo MV; Lee SB; Garofano L; Zhang J; Shi P; Lewis G; Sanson H; Frederick V; Castano AM; Cerulo L; Rolland DCM; Mall R; Mokhtari K; Elenitoba-Johnson KSJ; Sanson M; Huang X; Ceccarelli M; Lasorella A; Iavarone A
    Nature; 2018 Jan; 553(7687):222-227. PubMed ID: 29323298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting gene fusions in glioma.
    Kim PL
    Curr Opin Neurol; 2021 Dec; 34(6):840-847. PubMed ID: 34766555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.
    Davare MA; Henderson JJ; Agarwal A; Wagner JP; Iyer SR; Shah N; Woltjer R; Somwar R; Gilheeney SW; DeCarvalo A; Mikkelson T; Van Meir EG; Ladanyi M; Druker BJ
    Clin Cancer Res; 2018 Dec; 24(24):6471-6482. PubMed ID: 30171048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.
    Granberg KJ; Annala M; Lehtinen B; Kesseli J; Haapasalo J; Ruusuvuori P; Yli-Harja O; Visakorpi T; Haapasalo H; Nykter M; Zhang W
    Neuro Oncol; 2017 Sep; 19(9):1206-1216. PubMed ID: 28379477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions.
    Shugay M; Ortiz de Mendíbil I; Vizmanos JL; Novo FJ
    Bioinformatics; 2013 Oct; 29(20):2539-46. PubMed ID: 23956304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma.
    Wu Y; Jin W; Wang Q; Zhou J; Wang Y; Tan Y; Cui X; Tong F; Yang E; Wang J; Kang C
    Mol Ther; 2021 Nov; 29(11):3305-3318. PubMed ID: 34274537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples.
    Kurobe M; Kojima T; Nishimura K; Kandori S; Kawahara T; Yoshino T; Ueno S; Iizumi Y; Mitsuzuka K; Arai Y; Tsuruta H; Habuchi T; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Kakehi Y; Nagumo Y; Tsutsumi M; Oikawa T; Kikuchi K; Nishiyama H
    PLoS One; 2016; 11(12):e0165109. PubMed ID: 27930669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastomas harboring gene fusions detected by next-generation sequencing.
    Woo HY; Na K; Yoo J; Chang JH; Park YN; Shim HS; Kim SH
    Brain Tumor Pathol; 2020 Oct; 37(4):136-144. PubMed ID: 32761533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of Noncanonical RET Fusions in Non-Small-Cell Lung Cancer through DNA and RNA Sequencing.
    Xiang C; Guo L; Zhao R; Teng H; Wang Y; Xiong L; Han Y
    J Mol Diagn; 2022 Apr; 24(4):374-385. PubMed ID: 35063667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Gliomas with FGFR3-TACC3 Fusions: Oncogenic Mechanisms, Hallmarks, and Therapeutic Perspectives.
    Picca A; Sansone G; Santonocito OS; Mazzanti CM; Sanson M; Di Stefano AL
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
    van Belzen IAEM; Cai C; van Tuil M; Badloe S; Strengman E; Janse A; Verwiel ETP; van der Leest DFM; Kester L; Molenaar JJ; Meijerink J; Drost J; Peng WC; Kerstens HHD; Tops BBJ; Holstege FCP; Kemmeren P; Hehir-Kwa JY
    BMC Cancer; 2023 Jul; 23(1):618. PubMed ID: 37400763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.
    Bielle F; Di Stefano AL; Meyronet D; Picca A; Villa C; Bernier M; Schmitt Y; Giry M; Rousseau A; Figarella-Branger D; Maurage CA; Uro-Coste E; Lasorella A; Iavarone A; Sanson M; Mokhtari K
    Brain Pathol; 2018 Sep; 28(5):674-683. PubMed ID: 28976058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma.
    Gött H; Uhl E
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers.
    Tsang ES; Grisdale CJ; Pleasance E; Topham JT; Mungall K; Reisle C; Choo C; Carreira M; Bowlby R; Karasinska JM; MacMillan D; Williamson LM; Chuah E; Moore RA; Mungall AJ; Zhao Y; Tessier-Cloutier B; Ng T; Sun S; Lim HJ; Schaeffer DF; Renouf DJ; Yip S; Laskin J; Marra MA; Jones SJM; Loree JM
    Clin Cancer Res; 2021 Jan; 27(2):522-531. PubMed ID: 33148671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.